Medical Care

Global Autoimmune Disease Therapeutics Market Research Report 2024

The global Autoimmune Disease Therapeutics market was valued at US$ 98160 million in 2023 and is anticipated to reach US$ 119350 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Autoimmune Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Autoimmune Disease Therapeutics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Autoimmune Disease Therapeutics in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Autoimmune Disease Therapeutics include Pfizer, Novartis, Johnson & Johnson Services, Merck, Sanofi, Abott, Bristol-Myers Squibb, Amgen and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Therapeutics.
Report Scope
The Autoimmune Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol-Myers Squibb
Amgen
Bayer
F. Hoffmann-La Roche
Eli Lilly and Company
Segment by Type
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Others
Segment by Application
Hospitals
Clinics
Independent Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunosuppressants
1.2.3 Anti-Inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Nonsteroidal Anti-inflammatory Drugs
1.2.6 Biologics
1.2.7 Others
1.3 Market by Application
1.3.1 Global Autoimmune Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Independent Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Therapeutics Market Perspective (2019-2030)
2.2 Autoimmune Disease Therapeutics Growth Trends by Region
2.2.1 Global Autoimmune Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autoimmune Disease Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Autoimmune Disease Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Autoimmune Disease Therapeutics Market Dynamics
2.3.1 Autoimmune Disease Therapeutics Industry Trends
2.3.2 Autoimmune Disease Therapeutics Market Drivers
2.3.3 Autoimmune Disease Therapeutics Market Challenges
2.3.4 Autoimmune Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Therapeutics Players by Revenue
3.1.1 Global Top Autoimmune Disease Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Autoimmune Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Autoimmune Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Therapeutics Revenue
3.4 Global Autoimmune Disease Therapeutics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Therapeutics Revenue in 2023
3.5 Autoimmune Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Therapeutics Breakdown Data by Type
4.1 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2025-2030)
5 Autoimmune Disease Therapeutics Breakdown Data by Application
5.1 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autoimmune Disease Therapeutics Market Size (2019-2030)
6.2 North America Autoimmune Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Autoimmune Disease Therapeutics Market Size by Country (2019-2024)
6.4 North America Autoimmune Disease Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Disease Therapeutics Market Size (2019-2030)
7.2 Europe Autoimmune Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Autoimmune Disease Therapeutics Market Size by Country (2019-2024)
7.4 Europe Autoimmune Disease Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Autoimmune Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Disease Therapeutics Market Size (2019-2030)
9.2 Latin America Autoimmune Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Autoimmune Disease Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Autoimmune Disease Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Autoimmune Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Autoimmune Disease Therapeutics Introduction
11.1.4 Pfizer Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Autoimmune Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Detail
11.3.2 Johnson & Johnson Services Business Overview
11.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Introduction
11.3.4 Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.3.5 Johnson & Johnson Services Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Autoimmune Disease Therapeutics Introduction
11.4.4 Merck Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Autoimmune Disease Therapeutics Introduction
11.5.4 Sanofi Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Abott
11.6.1 Abott Company Detail
11.6.2 Abott Business Overview
11.6.3 Abott Autoimmune Disease Therapeutics Introduction
11.6.4 Abott Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.6.5 Abott Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Autoimmune Disease Therapeutics Introduction
11.8.4 Amgen Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.8.5 Amgen Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Autoimmune Disease Therapeutics Introduction
11.9.4 Bayer Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.9.5 Bayer Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Detail
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Detail
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Introduction
11.11.4 Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2019-2024)
11.11.5 Eli Lilly and Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunosuppressants
Table 3. Key Players of Anti-Inflammatory Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 6. Key Players of Biologics
Table 7. Key Players of Others
Table 8. Global Autoimmune Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Autoimmune Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Autoimmune Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Autoimmune Disease Therapeutics Market Share by Region (2019-2024)
Table 12. Global Autoimmune Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Autoimmune Disease Therapeutics Market Share by Region (2025-2030)
Table 14. Autoimmune Disease Therapeutics Market Trends
Table 15. Autoimmune Disease Therapeutics Market Drivers
Table 16. Autoimmune Disease Therapeutics Market Challenges
Table 17. Autoimmune Disease Therapeutics Market Restraints
Table 18. Global Autoimmune Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Autoimmune Disease Therapeutics Market Share by Players (2019-2024)
Table 20. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2023)
Table 21. Ranking of Global Top Autoimmune Disease Therapeutics Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Autoimmune Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Autoimmune Disease Therapeutics Product Solution and Service
Table 25. Date of Enter into Autoimmune Disease Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Autoimmune Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2019-2024)
Table 29. Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2025-2030)
Table 31. Global Autoimmune Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2019-2024)
Table 33. Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2025-2030)
Table 35. North America Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Autoimmune Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Autoimmune Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Autoimmune Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Autoimmune Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Autoimmune Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Autoimmune Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Autoimmune Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Autoimmune Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer Autoimmune Disease Therapeutics Product
Table 53. Pfizer Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Novartis Company Detail
Table 56. Novartis Business Overview
Table 57. Novartis Autoimmune Disease Therapeutics Product
Table 58. Novartis Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 59. Novartis Recent Development
Table 60. Johnson & Johnson Services Company Detail
Table 61. Johnson & Johnson Services Business Overview
Table 62. Johnson & Johnson Services Autoimmune Disease Therapeutics Product
Table 63. Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 64. Johnson & Johnson Services Recent Development
Table 65. Merck Company Detail
Table 66. Merck Business Overview
Table 67. Merck Autoimmune Disease Therapeutics Product
Table 68. Merck Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 69. Merck Recent Development
Table 70. Sanofi Company Detail
Table 71. Sanofi Business Overview
Table 72. Sanofi Autoimmune Disease Therapeutics Product
Table 73. Sanofi Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Abott Company Detail
Table 76. Abott Business Overview
Table 77. Abott Autoimmune Disease Therapeutics Product
Table 78. Abott Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 79. Abott Recent Development
Table 80. Bristol-Myers Squibb Company Detail
Table 81. Bristol-Myers Squibb Business Overview
Table 82. Bristol-Myers Squibb Autoimmune Disease Therapeutics Product
Table 83. Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Amgen Company Detail
Table 86. Amgen Business Overview
Table 87. Amgen Autoimmune Disease Therapeutics Product
Table 88. Amgen Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 89. Amgen Recent Development
Table 90. Bayer Company Detail
Table 91. Bayer Business Overview
Table 92. Bayer Autoimmune Disease Therapeutics Product
Table 93. Bayer Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 94. Bayer Recent Development
Table 95. F. Hoffmann-La Roche Company Detail
Table 96. F. Hoffmann-La Roche Business Overview
Table 97. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Product
Table 98. F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 99. F. Hoffmann-La Roche Recent Development
Table 100. Eli Lilly and Company Company Detail
Table 101. Eli Lilly and Company Business Overview
Table 102. Eli Lilly and Company Autoimmune Disease Therapeutics Product
Table 103. Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 104. Eli Lilly and Company Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Autoimmune Disease Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Immunosuppressants Features
Figure 4. Anti-Inflammatory Drugs Features
Figure 5. Corticosteroids Features
Figure 6. Nonsteroidal Anti-inflammatory Drugs Features
Figure 7. Biologics Features
Figure 8. Others Features
Figure 9. Global Autoimmune Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Autoimmune Disease Therapeutics Market Share by Application: 2023 VS 2030
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Independent Pharmacies Case Studies
Figure 14. Others Case Studies
Figure 15. Autoimmune Disease Therapeutics Report Years Considered
Figure 16. Global Autoimmune Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Autoimmune Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Autoimmune Disease Therapeutics Market Share by Region: 2023 VS 2030
Figure 19. Global Autoimmune Disease Therapeutics Market Share by Players in 2023
Figure 20. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Therapeutics as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Autoimmune Disease Therapeutics Revenue in 2023
Figure 22. North America Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Autoimmune Disease Therapeutics Market Share by Country (2019-2030)
Figure 24. United States Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Autoimmune Disease Therapeutics Market Share by Country (2019-2030)
Figure 28. Germany Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Region (2019-2030)
Figure 36. China Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Autoimmune Disease Therapeutics Market Share by Country (2019-2030)
Figure 44. Mexico Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Country (2019-2030)
Figure 48. Turkey Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Autoimmune Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Pfizer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 51. Novartis Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 52. Johnson & Johnson Services Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 53. Merck Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 54. Sanofi Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 55. Abott Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 57. Amgen Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 58. Bayer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 59. F. Hoffmann-La Roche Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 60. Eli Lilly and Company Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies